Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib

NCT02621047 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche